Ethics Watchdog Urges Investigation Into Top Health Official, Alleging Conflict of Interest Over Hormone Therapy Policy

Feed excerpt — reported by ProPublica

The complaint follows a ProPublica investigation that found Alicia Jackson, a high-ranking federal health official, publicly endorsed a  change in hormone therapy policy while owning stock in a company that provides access to menopause treatments.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at ProPublica →

View MAP Context →